Clinical Trial Update: CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry [NA]

View source ↗

Summary

Clinical trial update for CyberKnife radiosurgery in low and intermediate risk prostate cancer; results regarding emulating HDR brachytherapy dosimetry have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• CyberKnife radiosurgery

Snippet

Sponsor: Accuray Incorporated | Conditions: Prostate Cancer, Prostatic Cancer | NA | Status: COMPLETED | Results posted: 2023-05-09